Dramatic drop in new cancer drug trials during the COVID-19 pandemic
Emma Wilkinson
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)Clinical trial2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug trialCancer drugsMedicineDrugCancerIntensive care medicineOncologyVirologyInternal medicinePharmacologyInfectious disease (medical specialty)DiseaseOutbreakScience, Research, and MedicineEconomic and Financial Impacts of CancerCOVID-19 and healthcare impacts